In this video, Amy Burd, PhD, Leukemia & Lymphoma Society, New York, NY, highlights some of the patient-reported outcomes explored in the Beat AML clinical trial (NCT03013998). This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.